List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2897 studies with search of:   United States, Oregon
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: letrozole;   Drug: placebo;   Drug: tamoxifen citrate
2 Active, not recruiting Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cetuximab;   Drug: paclitaxel
3 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
4 Active, not recruiting Effects of Anti-HIV Therapy on Nervous System Function
Condition: HIV Infections
Intervention:
5 Recruiting Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Drug: placebo
6 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
7 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
8 Active, not recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
9 Active, not recruiting Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Intervention: Drug: erlotinib hydrochloride
10 Active, not recruiting Urine and Blood Protein Levels in Predicting One-Year Recurrence of Glioblastoma Multiforme in Patients Undergoing Radiation Therapy
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: laboratory biomarker analysis;   Procedure: radiation therapy
11 Recruiting Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: denileukin diftitox;   Drug: rituximab;   Procedure: flow cytometry;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis
12 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
13 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid;   Osteoarthritis
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
14 Recruiting Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
Condition: Breast Cancer
Intervention: Procedure: chemotherapy
15 Recruiting Combination Chemotherapy in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
16 Active, not recruiting Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: placebo;   Drug: sorafenib tosylate
17 Active, not recruiting Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
Condition: Sarcoma
Intervention: Drug: sorafenib tosylate
18 Active, not recruiting Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: tositumomab and iodine I 131 tositumomab;   Drug: vincristine sulfate
19 Active, not recruiting Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: goserelin;   Drug: mitoxantrone hydrochloride;   Drug: prednisone;   Procedure: adjuvant therapy;   Procedure: radiation therapy
20 Active, not recruiting Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: irinotecan hydrochloride;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services